Core Insights - The company experienced a strong financial performance in 2025, with total revenue growth exceeding 20% and earnings per share increasing by over 70% [3][10][17] - The semiconductor and data center markets showed significant growth, with data center revenue more than doubling year on year [2][15] - The company expects continued growth in 2026, driven by new product introductions and a recovery in the industrial medical market [7][8][20] Financial Performance - Revenue for Q4 2025 reached nearly $490 million, marking a 6% sequential increase and an 18% year-over-year growth [3][10] - Gross margin improved to just shy of 40%, the best performance in five years, with operating cash flow reaching a record $235 million [3][10][17] - For the full year 2025, total revenue was $1.8 billion, up 21% year over year, with semiconductor revenue at $840 million, a 6% increase [15][17] Market Dynamics - The industrial medical market saw a sequential revenue increase of 10% in Q4, returning to year-over-year growth after two years of decline [6][11] - Data center computing revenue was a record $178 million in Q4, up 101% year over year, driven by AI data center investments [11][15] - The company anticipates that the semiconductor market will see stronger demand in the second half of 2026, supported by customer forecasts [7][25] Product Development and Strategy - The company launched 26 new products in 2025 and expects to continue leveraging its design win pipeline for future growth [1][2][4] - Investments in new product development, customization capabilities, and digital marketing are expected to enhance market share in the industrial medical sector [5][60] - The company is focused on expanding its manufacturing capacity, including a new factory in Thailand expected to generate over $1 billion in annual revenue capacity [5][21][38] Future Outlook - The company projects high teens revenue growth for 2026, following a 21% growth in 2025, with expectations of over 30% growth in the data center segment [8][20] - Gross margin is expected to exceed 40% in 2026, supported by improved efficiency and a favorable product mix [6][21][48] - The company is actively pursuing acquisition opportunities to expand its technology portfolio, particularly in the industrial and medical sectors [54][60]